Pinaverium bromide
![]() | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H41Br2NO4 |
Molar mass | 591.425 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Pinaverium bromide (INN) is a medication used for functional gastrointestinal disorders. It belongs to a drug group called antispasmodics and acts as a calcium channel blocker in helping to restore the normal contraction process of the bowel. It is most effective when taken for a full course of treatment and is not designed for immediate symptom relief or sporadic, intermittent use.
Pinaverium bromide was first registered in 1975 by Solvay Pharmaceuticals (now a division of Abbott Laboratories), and marketed globally using the brand names Dicetel and Eldicet. Generic pinaverium is available in South Korea under a trade name of Disten[1] and in Argentina as Nulite.[2]
Indications
It is indicated for the treatment and relief of symptoms associated with irritable bowel syndrome (IBS) including abdominal pain, bowel disturbances and intestinal discomfort; and treatment of symptoms related to functional disorders of biliary tract.[3]
References
- ^ KMLE 약품/의약품 정보: 디스텐정 (Disten Tab.) (in Korean)
- ^ "NULITE | Laboratorio Dominguez".
- ^ Abbott Laboratories (Feb 2012). Dicetel Product Insert/Information Malaysia.
{{cite book}}
: CS1 maint: year (link)